Literature DB >> 12731862

Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).

Elaine M Leslie1, Isabelle J Létourneau, Roger G Deeley, Susan P C Cole.   

Abstract

The 190 kDa multidrug resistance protein 1 (MRP1; ABCC1) is comprised of three membrane spanning domains (MSDs) and two nucleotide binding domains (NBDs) configured MSD1-MSD2-NBD1-MSD3-NBD2. MRP1 overexpression in tumor cells results in an ATP-dependent efflux of many oncolytic agents and arsenic and antimony oxyanions. MRP1 also transports GSSG and GSH as well as conjugated organic anions, including leukotriene C(4) and 17beta-estradiol 17-(beta-D-glucuronide) and certain xenobiotics in association with GSH. Previous studies have shown that portions of MSD1 and the cytoplasmic loop (CL3) connecting it to MSD2 are important for MRP1 transport function. In the present study, Cys residues at positions 43, 49, 85, 148, and 190 in MSD1 and positions 208 and 265 in CL3 were mutated to Ala and Ser, and the effects on protein expression, plasma membrane localization, trypsin sensitivity, organic anion transport, and drug resistance properties were investigated. Confocal microscopy showed that 11 of 14 mutants displayed significant levels of nonplasma membrane-associated MRP1. Most mutant proteins were also more resistant to trypsin proteolysis than wild-type MRP1. All Cys mutants transported organic anions (0.5-1.5-fold wild-type MRP1 activity), and cells expressing Ser-substituted but not Ala-substituted Cys43 and Cys265 MRP1 mutants exhibited a 2.5-fold decrease and a 3-fold increase in arsenite resistance, respectively; Cys43Ser MRP1 also conferred lower levels of vincristine resistance. These results indicate that certain Cys residues in the NH(2) proximal region of MRP1 can be important for its structure and selected transport activities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731862     DOI: 10.1021/bi027076n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.

Authors:  Jing Zhao; Bing-Yun Yu; Dao-Yuan Wang; Jin-E Yang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

3.  Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking.

Authors:  Christopher J Westlake; Susan P C Cole; Roger G Deeley
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

Review 4.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.

Authors:  Xiaokun Cai; Zsolt Bikadi; Zhanglin Ni; Eun-Woo Lee; Honggang Wang; Mark F Rosenberg; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2010-03-04       Impact factor: 4.030

Review 6.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

7.  Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population.

Authors:  Ji-Ye Yin; Qiong Huang; Youyun Yang; Jian-Ting Zhang; Mei-Zuo Zhong; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

8.  Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.

Authors:  Federico Innocenti; Deanna L Kroetz; Erin Schuetz; M Eileen Dolan; Jacqueline Ramírez; Mary Relling; Peixian Chen; Soma Das; Gary L Rosner; Mark J Ratain
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

Review 9.  Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy.

Authors:  Abhishek Gulati; Phillip M Gerk
Journal:  J Pharm Sci       Date:  2009-07       Impact factor: 3.534

10.  Structure of a human multidrug transporter in an inward-facing conformation.

Authors:  Mark F Rosenberg; Curtis J Oleschuk; Peng Wu; Qingcheng Mao; Roger G Deeley; Susan P C Cole; Robert C Ford
Journal:  J Struct Biol       Date:  2010-01-28       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.